摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-二甲基苯基异硫氰酸酯 | 40046-30-8

中文名称
3,5-二甲基苯基异硫氰酸酯
中文别名
3,5-二甲基苯基硫代异氰酸酯
英文名称
3,5-dimethylphenyl isothiocyanate
英文别名
1-isothiocyanato-3,5-dimethylbenzene
3,5-二甲基苯基异硫氰酸酯化学式
CAS
40046-30-8
化学式
C9H9NS
mdl
MFCD00041082
分子量
163.243
InChiKey
DSMXCADWIFIJEX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    140 °C
  • 密度:
    1.01±0.1 g/cm3(Predicted)
  • 稳定性/保质期:
    常规情况下不会分解,也没有任何危险反应。

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    44.4
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    6.1
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R20/21/22,R36/37/38
  • 危险品标志:
    Xn
  • 危险品运输编号:
    2810
  • 海关编码:
    2930909090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P310+P330,P302+P352+P332+P313+P362+P364,P304+P340+P311,P305+P351+P338+P337+P313,P403+P233,P405,P501
  • 危险性描述:
    H301+H331,H315,H319,H335
  • 储存条件:
    密封、阴凉、干燥保存。

SDS

SDS:fba1f6bb641d3761e0255271bc509a93
查看
Name: 3 5-Dimethylphenyl isothiocyanate 97% Material Safety Data Sheet
Synonym:
CAS: 40046-30-8
Section 1 - Chemical Product MSDS Name:3 5-Dimethylphenyl isothiocyanate 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
40046-30-8 3,5-Dimethylphenyl isothiocyanate 97% unlisted
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye irritation. Lachrymator (substance which increases the flow of tears).
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 40046-30-8: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless - pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 140 - 142 deg C @15mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H9NS
Molecular Weight: 163.24

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Bases, oxidizing agents, reducing agents, amines.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 40046-30-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,5-Dimethylphenyl isothiocyanate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 40046-30-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 40046-30-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 40046-30-8 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,5-二甲基苯基异硫氰酸酯 在 sodium azide 作用下, 以 为溶剂, 生成 1-(3,5-dimethylphenyl)-1H-tetrazole-5-thiol
    参考文献:
    名称:
    A novel copper(I) sulfamate π-complex based on the 5-(allylthio)-1-(3,5-dimethylphenyl)-1H-tetrazole ligand: Alternating-current electrochemical crystallization, DFT calculations, structural and NLO properties studies
    摘要:
    Using the alternating-current electrochemical technique, the novel pi-complex [Cu-1(m-dmphast)NH2 SO3](1), based on the 5-(allylthio)-1-(3,5-dimethylphenyl)-1H-tetrazole (m-dmphast) ligand, was obtained and it was studied by single crystal X-ray diffraction as well as IR and UV-Vis spectroscopy. The structure 1 should be considered as the first known example of a metal sulfamate coordination compound with a tetrazole ligand. The copper(I) ion in 1 possesses a trigonal pyramidal environment, arranged from the N4 atom of the tetrazole core, the C=C bond from the S-allyl group of the same m-dmphast ligand and O and N atoms of the NH2SO3- anions. The sulfamate anion is coordinated to the two neighboring Cu(I) ions in a bridged mode, occupying a basal plane (through the N atom) and an apical (through an O atom) position of the two neighboring metal trigonal pyramids. The bicolor coherent photoinduced treatment by a nanosecond Nd:YAG laser at a wavelength of 1064 nm caused the occurrence of charge density acentricity, which in turn favours an occurrence of second harmonic generation described by third rank polar tensors, that are usually forbidden for centrosymmerical crystals. (C) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.poly.2018.03.015
  • 作为产物:
    描述:
    o-phenyl (3,5-dimethylphenyl)carbamothioate 在 sodium hydroxide 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以98%的产率得到3,5-二甲基苯基异硫氰酸酯
    参考文献:
    名称:
    通过一锅法或两步法通过胺与氯邻苯二甲酸酯反应来合成异硫氰酸酯
    摘要:
    摘要 描述了一种由胺容易且有效地合成异硫氰酸酯的方法。该方法涉及通过一锅法或两步法在固体氢氧化钠存在下使胺与氯代硫代甲酸苯酯反应。一锅法可用于制备烷基和电子富集的芳基异硫氰酸酯,而两步法则更具通用性,不仅对烷基和电子富集的芳基异硫氰酸酯,而且对于高度缺电子的芳基和芳烃都非常有效。杂环异硫氰酸酯。 描述了一种由胺容易且有效地合成异硫氰酸酯的方法。该方法涉及通过一锅法或两步法在固体氢氧化钠存在下使胺与氯代硫代甲酸苯酯反应。一锅法可用于制备烷基和电子富集的芳基异硫氰酸酯,而两步法则更具通用性,不仅对烷基和电子富集的芳基异硫氰酸酯,而且对于高度缺电子的芳基和芳烃都非常有效。杂环异硫氰酸酯。
    DOI:
    10.1055/s-0033-1338744
点击查看最新优质反应信息

文献信息

  • Synthesis and antitumor activity of novel pyridazinone derivatives containing 1,3,4-thiadiazole moiety
    作者:Junhu Qin、Mei Zhu、Hongmei Zhu、Liqiong Zhang、Yihong Fu、Jiamin Liu、Zhenchao Wang、Guiping OuYang
    DOI:10.1080/10426507.2020.1737062
    日期:2020.7.2
    4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One), it exhibited good anticancer activity on MGC-803 cells. Besides, introducing fluorine, chlorine, or trifluoromethyl group onto the benzene ring, such as compound 5 m (2-(Tert-butyl)−4-chloro-5-((5-((4-(trifluoromethoxy)phenyl)amino)−1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One), displayed good anticancer activity on MGC-803 and Bcap-37 cells. Graphical Abstract
    摘要 合成了一系列含有1,3,4-噻二唑部分的新型哒嗪酮衍生物,并通过1H NMR、13C NMR、HRMS和IR光谱表征。其中,化合物5c的结构(2-(叔丁基)-4-氯-5-((5-((2-乙基苯基)氨基)-1,3,4-噻二唑-2-基)硫基)通过单晶 X 射线衍射分析明确证实了哒嗪-3(2H)-One)。通过MTT法测定所有目标化合物对MGC-803和Bcap-37的抑制活性,以阿霉素(抑制率分别为95.5±0.4%和95.7±1.0%)为对照。初步结果表明化合物5n(2-(叔丁基)-4-氯-5-((5-((3-氟苯基)氨基)-1,3,4-噻二唑-2-基) )thio)pyridazin-3(2H)-One) 优于其他。MGC-803和Bcap-37细胞在10 μmol/L浓度下的抑制率分别为86.3±2.2%和92.3±0.6%。初步的构效关系表明,当苯环的2-位被甲基取代时,如化合物
  • “On Water”: Efficient Iron-Catalyzed Cycloaddition of Aziridines with Heterocumulenes
    作者:Mani Sengoden、Tharmalingam Punniyamurthy
    DOI:10.1002/anie.201207746
    日期:2013.1.7
    In suspension: The reaction of aziridines with heterocumulenes in the presence of Fe(NO3)3⋅9 H2O in aqueous suspension provides access to functionalized five‐membered heterocycles in good to high yields. This protocol has a wide substrate scope, is simple, and uses a nontoxic and cheap catalyst.
    在悬浮液中:氮丙啶与在Fe的存在heterocumulenes反应(NO 3)3 ⋅9ħ 2 ö在水性悬浮液中提供了访问以良好至高产率官能五元杂环。该方案具有广泛的底物范围,简单且使用无毒且廉价的催化剂。
  • One-Pot Synthesis of 3-Arylquinazoline-2,4(1H,3H)-dithiones by the Reaction of 2-Lithiophenyl Isothiocyanates with Aryl Isothiocyanates
    作者:Kazuhiro Kobayashi、Yuki Yokoi、Hisatoshi Konishi
    DOI:10.1055/s-0030-1260016
    日期:2011.5
    synthesized in satisfactory yields from 2-bromophenyl isothiocyanates in one pot via generation of the corresponding 2-lithiophenyl isothiocyanates by bromine-lithium exchange with butyllithium followed by treatment with aryl isothiocyanates. quinazoline-2,4(1H,3H)-dithiones - 2-lithiophenyl isothiocyanates - 2-bromophenyl isothiocyanates - aryl isothiocyanates - benzothioamides
    一锅中由2-溴苯基异硫氰酸酯通过溴-锂与丁基锂的交换生成相应的2-硫代苯基异硫氰酸酯,然后用芳基处理,以令人满意的收率合成了3-芳基喹唑啉-2,4(1 H,3 H)-二硫酮异硫氰酸酯。 喹唑啉-2,4(1 H,3 H)-二硫酮-2-异硫氰酸异硫氰酸酯酯-2-异硫氰酸异溴苯基酯-异硫氰酸芳基酯-苯并硫代酰胺
  • Synthesis and Octopaminergic-agonist Activity of 3-(Substituted Phenyl)imidazolidine-2-thiones and Related Compounds
    作者:Akinori HIRASHIMA、Kenji SHINKAI、Eiichi KUWANO、Eiji TANIGUCHI、Morifusa ETO
    DOI:10.1271/bbb.62.1179
    日期:1998.1
    3-(Substituted phenyl)imidazolidine-2-thiones (SPITs) and related compounds were synthesized by cyclizing monoethanolamine hydrogen sulfate with arylisothiocyanates in the presence of sodium hydroxide. The activity for stimulating adenylate cyclase prepared from thoracic nerve cords of the American cockroach, Periplaneta americana L., was examined with these compounds. A SPIT with a 2,6-diethylphenyl
    通过在氢氧化钠存在下将单乙醇胺硫酸氢盐与芳基异硫氰酸酯环化,可以合成3-(取代的苯基)咪唑烷-2-硫酮(SPIT)和相关化合物。用这些化合物检查了刺激从美国蟑螂美洲大i的胸神经线制备的腺苷酸环化酶的活性。具有2,6-二乙基苯基基团的SPIT(48)是唯一的完全激动剂,其他SPIT衍生物是部分激动剂。更大的酶活化似乎是由短链烷基而不是SPITs芳香环的2,6-位上的卤素取代引起的。在2,6-二取代的SPIT中,从甲基到乙基的链长增加导致酶激活增加。同时,在2中,从乙基到异丙基的链长进一步增加 6-二取代的SPIT导致酶活化降低。能量最小的章鱼胺和48的叠加显示出结构和构象相似,这说明48的Vmax值更高。在有效SPIT的咪唑烷环的C4或C5烷基化后,酶的活化作用明显降低。因此,在SPIT的苯环和N-末端的2-位和6-位的一定程度的蓬松度和疏水性对于活化腺苷酸环化酶是有利的。
  • Preparation of 2-Azido-1-Substituted-1 <i>H</i>-Benzo[<i>d</i>]imidazoles Using a Copper-Promoted Three-Component Reaction and Their Further Conversion into 2-Amino and 2-Triazolyl Derivatives
    作者:Tamminana Ramana、Tharmalingam Punniyamurthy
    DOI:10.1002/chem.201202215
    日期:2012.10.15
    Multicomponent reaction: 2‐Azido‐1‐substituted‐1H‐benzo[d]imidazoles were prepared using a copper‐catalyzed three‐component reaction involving 2‐bromoaniline derivatives, isothiocyanates, and sodium azide. The reaction conditions were mild and the scope was broad. The azido compounds were transformed into their 2‐amino and 2‐triazolyl derivatives using copper‐mediated reduction and cycloaddition, respectively
    多组分反应:使用2-铜苯胺衍生物,异硫氰酸盐和叠氮化钠的铜催化三组分反应制备2-叠氮基-1-取代-1 H-苯并[ d ]咪唑。反应条件温和,适用范围广。分别通过铜介导的还原和环加成将叠氮基化合物转化为它们的2-氨基和2-三唑基衍生物(参见方案)。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐